APA

Farragher T. M., Lunt M., Plant D., Bunn D. K., Barton A. & Symmons D. P. M. (20100601). Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies. : Arthritis care & research.

Chicago

Farragher Tracey M, Lunt Mark, Plant Darren, Bunn Diane K, Barton Anne and Symmons Deborah P M. 20100601. Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies. : Arthritis care & research.

Harvard

Farragher T. M., Lunt M., Plant D., Bunn D. K., Barton A. and Symmons D. P. M. (20100601). Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies. : Arthritis care & research.

MLA

Farragher Tracey M, Lunt Mark, Plant Darren, Bunn Diane K, Barton Anne and Symmons Deborah P M. Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies. : Arthritis care & research. 20100601.